Showing results (881-890 of 1,990) with videos related to
Sort By:
Pageof 199
Prostate Cancer and Prostatic Diseases|April 23, 2008
Race and prostate weight as independent predictors for biochemical recurrence after radical prostatectomyF R Schroeck, L Sun, S J Freedland, et al.Prostate Cancer and Prostatic Diseases|April 9, 2008
Brachytherapy for advanced prostate cancer bleedingR Thurairaja, R Pocock, M Crundwell, et al.Prostate Cancer and Prostatic Diseases|February 13, 2014
EP2 signaling mediates suppressive effects of celecoxib on androgen receptor expression and cell proliferation in prostate cancerE Kashiwagi, M Shiota, A Yokomizo, et al.Prostate Cancer and Prostatic Diseases|June 4, 2008
Prostate cancer chemotherapy in the era of targeted therapyA Michael, K Syrigos, H PandhaProstate Cancer and Prostatic Diseases|March 12, 2014
A double-blind, placebo-controlled randomised trial evaluating the effect of a polyphenol-rich whole food supplement on PSA progression in men with prostate cancer--the U.K. NCRN Pomi-T studyR Thomas, M Williams, H Sharma, et al.Prostate Cancer and Prostatic Diseases|November 3, 2018
Higher baseline dietary fat and fatty acid intake is associated with increased risk of incident prostate cancer in the SABOR studyMichael A Liss, Osamah Al-Bayati, Jonathan Gelfond, et al.Prostate Cancer and Prostatic Diseases|February 22, 2017
Impact of symptomatic skeletal events on health-care resource utilization and quality of life among patients with castration-resistant prostate cancer and bone metastasesR McKay, B Haider, M S Duh, et al.Prostate Cancer and Prostatic Diseases|February 22, 2017
Meta-analysis of metabolic syndrome and prostate cancerM Gacci, G I Russo, C De Nunzio, et al.Prostate Cancer and Prostatic Diseases|March 1, 2017
Imaging response during therapy with radium-223 for castration-resistant prostate cancer with bone metastases-analysis of an international multicenter databaseD Keizman, M O Fosboel, H Reichegger, et al.Prostate Cancer and Prostatic Diseases|March 21, 2019
Association of prostate cancer SLCO gene expression with Gleason grade and alterations following androgen deprivation therapyMazen Alsinnawi, Ailin Zhang, Daniella Bianchi-Frias, et al.Pageof 199